Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Elderly Medical Patients
2014-000311-13Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in venous thromboembolism (VTE), deep vein thrombosis (DVT) and pulmonary embolism (PE) comparing Enoxaparin prophylaxis with Placebo (2 arms). Started Jun 2015; status: terminated.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on 2014-000311-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000311-13.